This trial will use a device to record electrical activity in the brain to detect patterns associated with PTSD, which will then be treated with electrical pulses in an attempt to improve symptoms.
7 Primary · 25 Secondary · Reporting Duration: quarterly during year 2-4
Experimental Treatment
6 Total Participants · 1 Treatment Group
Primary Treatment: NeuroPace® RNS® System · No Placebo Group · Phase < 1
Age 25 - 60 · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Washington | 33.3% |
Georgia | 33.3% |
Tennessee | 33.3% |
18 - 65 | 100.0% |
VA Greater Los Angeles | 100.0% |
Met criteria | 100.0% |
Phone Call | 100.0% |